#BEGIN_DRUGCARD DB03231

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C25H21N7O3S

# Chemical_IUPAC_Name:
3-{5-amino-7-hydroxy-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl}-N-[(2-{[2-(hydroxymethyl)phenyl]sulfanyl}phenyl)methyl]benzamide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-[2-(2-(Hydroxymethyl-Phenylsulfanyl)-Benzyl]-Benzamide

# HET_ID:
PSB

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C25H21N7O3S/c26-25-28-22-21(24(35)29-25)30-32(31-22)18-9-5-8-15(12-18)23(34)27-13-16-6-1-3-10-19(16)36-20-11-4-2-7-17(20)14-33/h1-12,33H,13-14H2,(H,27,34)(H3,26,28,29,31,35)

# InChI_Key:
InChIKey=IXDQOBDHBWEZOH-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3231

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
499.544

# Molecular_Weight_Mono:
499.142658263

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1RSD

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.49

# Predicted_LogS:
-4.8

# Predicted_Water_Solubility:
8.51e-03 g/l

# Primary_Accession_No:
DB03231

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
448408

# PubChem_Substance_ID:
46506254

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02670

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC2=NN(N=C2C(O)=N1)C1=CC=CC(=C1)C(=O)NCC1=CC=CC=C1SC1=CC=CC=C1CO

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:03 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
folB

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
9586996	Hennig M, D'Arcy A, Hampele IC, Page MG, Oefner C, Dale GE: Crystal structure and reaction mechanism of 7,8-dihydroneopterin aldolase from Staphylococcus aureus. Nat Struct Biol. 1998 May;5(5):357-62.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2360

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
13751

# Drug_Target_1_Name:
Dihydroneopterin aldolase

# Drug_Target_1_Number_of_Residues:
121

# Drug_Target_1_PDB_ID:
1RSI

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02152	FolB

# Drug_Target_1_Protein_Sequence:
>Dihydroneopterin aldolase
MQDTIFLKGMRFYGYHGALSAENEIGQIFKVDVTLKVDLSEAGRTDNVIDTVHYGEVFEE
VKSIMEGKAVNLLEHLAERIANRINSQYNRVMETKVRITKENPPIPGHYDGVGIEIVREN
K

# Drug_Target_1_Reaction:
2-amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8- dihydropteridine = 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine + glycolaldehyde

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the conversion of 7,8-dihydroneopterin to 6- hydroxymethyl-7,8-dihydropterin

# Drug_Target_1_SwissProt_ID:
P56740

# Drug_Target_1_SwissProt_Name:
FOLB_STAAU

# Drug_Target_1_Synonyms:
DHNA
EC 4.1.2.25

# Drug_Target_1_Theoretical_pI:
5.64

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03231
